CORRESP Filing
Quince Therapeutics, Inc.
Date: Aug. 1, 2025 · CIK: 0001662774 · Accession: 0001193125-25-171664
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288971
Letter
RE: Quince Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-288971 Ladies and Gentlemen: Quince Therapeutics, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on August 5, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Gordon Ho of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Gordon Ho of Cooley LLP, counsel to the Registrant, at (650) 843-5190.
Quince Therapeutics, Inc. 611 Gateway Boulevard, Suite 273 South San Francisco, CA 94080 August 1, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
Very truly yours,
QUINCE THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Quince Therapeutics, Inc. 611 Gateway Boulevard, Suite 273 South San Francisco, CA 94080 August 1, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Quince Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-288971 Ladies and Gentlemen: Quince Therapeutics, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on August 5, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Gordon Ho of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Gordon Ho of Cooley LLP, counsel to the Registrant, at (650) 843-5190. Very truly yours, QUINCE THERAPEUTICS, INC. By: / S / B RENDAN H ANNAH Name: Brendan Hannah Title: Chief Business Officer and Chief Operating Officer cc: Gordon Ho, Cooley LLP